Phase
Condition
Red Blood Cell Disorders
Lymphoproliferative Disorders
Platelet Disorders
Treatment
N/AClinical Study ID
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Relapsed or refractory multiple myeloma following 1 previous line of therapy and, isscheduled by the investigator to be treated with vincristine, adriamycin anddexamethasone standard therapy
measurable secretory multiple myeloma based on defined criteria
Karnofsky performance status of >or = 60%
fulfils defined laboratory requirements within 14 days before baseline
if female, the patient is either postmenopausal or surgically sterilised or willing touse an acceptable method of birth control for defined period of time
if male, the patient agrees to use an acceptable barrier method for contraception fora defined period of time.
Exclusion
Exclusion Criteria:
More than one previous line of therapy for multiple myeloma
use of bortezomib in the previous line of therapy and/or received bortezomib in aprevious trial
known allergy or hypersensitivity to bortezomib, boron or mannitol
peripheral neuropathy or neuropathic pain of grade 2 or higher
myocardial infarction within 6 months of enrollment or had New York Heart Association (NYHA) Class III or IV heart failure, uncontrolled angina, severe uncontrolledventricular arrhythmias, or electrocardiographic evidence of acute ischemia or activeconduction system abnormalities.
Study Design
Study Description
Connect with a study center
Zagreb,
CroatiaSite Not Available
Leer,
GermanySite Not Available
Velbert,
GermanySite Not Available
Debrecen,
HungarySite Not Available
Kaunas,
LithuaniaSite Not Available
Klaipeda,
LithuaniaSite Not Available
Vilnius,
LithuaniaSite Not Available
Bialystok,
PolandSite Not Available
Gdansk,
PolandSite Not Available
Poznan,
PolandSite Not Available
Moscow,
Russian FederationSite Not Available
Samara,
Russian FederationSite Not Available
St Petersburg,
Russian FederationSite Not Available
Ankara,
TurkeySite Not Available
Bursa,
TurkeySite Not Available
Eskisehir,
TurkeySite Not Available

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.